|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The St. Paul, Minnesota-based company said it had a loss of $1.06 per share. The medical device company posted revenue of $360,000 in the period. The company's shares closed at $1.61. A year ago, they ...
Zacks.com highlights: Avon Products, Altria Group, EnteroMedics, Macquarie Infrastructure and Sibanye Gold
Express Scripts Holding Company (ESRX) posted robust first-quarter numbers driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.
ST. PAUL, Minn., Oct. 23, 2017 /PRNewswire/ -- EnteroMedics Inc. (ETRM), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that the Company has formally changed its name to ReShape Lifesciences Inc. (NASDAQ:RSLS). The new name, effective today, reflects the Company's expansion and growth into a full-scale provider of medical devices to address the continuum of care for obesity and its associated health conditions. The Company's portfolio, designed to help patients lose weight and live a healthier life, includes two FDA-approved devices, the vBloc® System and ReShape® Integrated Dual Balloon System, as well as the Gastric Vest System™, an investigational device.
athenahealth (ATHN) witnessed a year-over-year increase in Q3 revenues on the back of strength in its Business and Services segment.
NEW YORK, NY / ACCESSWIRE / October 17, 2017 / All three major indexes notched record closes on Monday setting a positive tone for an important week of corporate earnings. The Dow Jones Industrial Average ...
ST. PAUL, Minn. , Oct. 16, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, ...
ST. PAUL, Minn. , Oct. 12, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, ...
The Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics
In view of the current political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable momentum picks.
NEW YORK, NY / ACCESSWIRE / October 4, 2017 / Mannkind and EnteroMedics saw gains yesterday after each company had positive news that had traders celebrating. Mannkind announced that the FDA has OK'ed ...
"EnteroMedics and ReShape Medical are two innovative companies that share a strong strategic focus on providing proprietary, patient-friendly technologies to address the global obesity epidemic," continued Gladney.